“I think everyone who wants it has already gotten it,” a health worker was told, holding a cooler of soon-to-expire COVID-19 vaccines doses. All went unused.    

A new Alzheimer’s drug has secured FDA approval for the first time in nearly 2 decades, and not everyone is happy about it.   Biogen’s new drug, Aduhelm, is expensive ($56,000 per year) and highly controversial:

Just when the stakes couldn’t be higher, America’s trust in public health is faltering, a new

The FDA’s approval of the first long-acting HIV drug combination yesterday promises to boost the quality of life for people under treatment—trading 3 daily pills for a monthly round of 2 injections, the

A double-blind trial of 160 patients in Argentina offered promising results for convalescent plasma as a COVID-19 treatment,

“It’s the best early birthday present I could wish for…”  

WHO advisors are meeting today to discuss deliberately infecting young, healthy volunteers with SARS-CoV-2 to hasten vaccine development—despite the promising vaccines already on the way.   Pros: Faster results than conventional vaccine field trials…

The UK vaulted over the US today in the race to immunize citizens against COVID-19 after it became the first Western country to approve the Pfizer/BioNTech vaccine under emergency authorization.

Following Pfizer's news that its COVID-19 vaccine shows 90% efficacy, Russia rushed to report that its Sputnik V vaccine candidate shows 92% efficacy, 

The dominant origin story of Alzheimer’s focuses on the build-up of amyloid protein “clumps” on the brain.